Results 41 to 50 of about 28,891 (186)
Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
The AKR1B10 (aldo-keto reductase family 1 member B10) gene has important functions in carcinogen-induced neoplasia. AKR1B10 is also expressed in type 2 reaction leprosy patients (R2).
Cleverson T. Soares +5 more
doaj +1 more source
Diagnosis and Management of Leprosy
Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which tends to attack peripheral nerves and skin. The diagnosis of leprosy is based on the presence of one of three cardinal signs. Early diagnosis of leprosy is critical
Medhi Denisa Alinda +6 more
doaj +1 more source
Association of a new FCN3 haplotype with high ficolin-3 levels in leprosy. [PDF]
Leprosy is a chronic inflammatory disease caused by Mycobacterium leprae that mainly affects the skin and peripheral nervous system, leading to a high disability rate and social stigma.
Fabiana Antunes Andrade +5 more
doaj +1 more source
Progress in research on immunological mechanism of leprosy
Leprosy is a chronic infection acquired after getting exposed to Mycobacterium leprae(M.Leprae), especially via contact or through nasal secretions of the affected hosts.
Benson Kiprono Kosgei
doaj +1 more source
Grade 2 disability among leprosy patients: A pilot study from an endemic area of Central India
Background and Aim: Deformities and disabilities in leprosy lead to significant morbidity to the individual and financial burden to the family. As the prevalence of leprosy is higher in central India, this study was conducted to know the burden of ...
Bada Shravani +6 more
doaj +1 more source
Lucio's phenomenon: exuberant case report and review of Brazilian cases [PDF]
Lucio’s phenomenon is an uncommon reaction characterized by severe necrotizing cutaneous lesions that occurs in patients with Lucio’s leprosy and lepromatous leprosy. It is considered by some authors as a variant of type 2 or 3 reaction.
Rafael Henrique Rocha +5 more
doaj +1 more source
Borderline" lepromatous leprosy"
No abstract ...
openaire +2 more sources
Report of two cases of lepromatous leprosy at an early age
Leprosy is an infectious disease that has a broad spectrum of clinical manifestations. Lepromatous leprosy has a deficient cellular immune response and high bacillary multiplication.
Gabriela Belmonte Dorilêo +3 more
doaj +1 more source
CD4+ Th17 cells discriminate clinical types and constitute a third subset of non Th1, Non Th2 T cells in human leprosy. [PDF]
BACKGROUND: Patients with localized tuberculoid and generalized lepromatous leprosy show respectively Th1 and Th2 cytokine profile. Additionally, other patients in both types of leprosy also show a non discriminating Th0 cytokine profile with both ...
Chaman Saini, V Ramesh, Indira Nath
doaj +1 more source
Anti-neutrophil cytoplasmic antibodies (ANCA) in the clinical forms of leprosy
Anti-neutrophil cytoplasmic antibodies (ANCA) are autoantibodies against enzymes present in primary granules of neutrophils and lysosomes of monocytes detected in systemic vasculitis and in other diseases, including infections, ANCA are markers of active
Ferraz, AAF +4 more
core +3 more sources

